Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Clinical Immunology (Orlando, Fla.)|July 6, 2016
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cellsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
International Journal of Nanomedicine|April 17, 2019
Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma responseMesha Saeed, Sara Zalba, Ann L B Seynhaeve, et al.
Frontiers in Immunology|January 14, 2017
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in PatientsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
Pharmaceutics|July 2, 2020
Quantification of Pharmacokinetic Profiles of PD-1/PD-L1 Antibodies by Validated ELISAsSara Zalba, Ana M Contreras-Sandoval, Eva Martisova, et al.
Communications Biology|April 16, 2026
CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironmentsDaniel Spengler, Serafim Korovin, Kirti Prakash, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2010
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cellsNadine Pouw, Elike Treffers-Westerlaken, Jaco Kraan, et al.
Cancer Gene Therapy|June 26, 2002
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancerCor H J Lamers, Ralph A Willemsen, Barbara A Luider, et al.
Cancers|May 21, 2020
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate EpitopeMesha Saeed, Erik Schooten, Mandy van Brakel, et al.
Plos One|May 29, 2014
The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunityAnne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, et al.
Oncoimmunology|May 6, 2015
The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunityAnne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Clinical Immunology (Orlando, Fla.)|July 6, 2016
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cellsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
International Journal of Nanomedicine|April 17, 2019
Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma responseMesha Saeed, Sara Zalba, Ann L B Seynhaeve, et al.
Frontiers in Immunology|January 14, 2017
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in PatientsYarne Klaver, Sabine C L van Steenbergen, Stefan Sleijfer, et al.
Pharmaceutics|July 2, 2020
Quantification of Pharmacokinetic Profiles of PD-1/PD-L1 Antibodies by Validated ELISAsSara Zalba, Ana M Contreras-Sandoval, Eva Martisova, et al.
Communications Biology|April 16, 2026
CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironmentsDaniel Spengler, Serafim Korovin, Kirti Prakash, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2010
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cellsNadine Pouw, Elike Treffers-Westerlaken, Jaco Kraan, et al.
Cancer Gene Therapy|June 26, 2002
Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancerCor H J Lamers, Ralph A Willemsen, Barbara A Luider, et al.
Cancers|May 21, 2020
T Cells Expressing a TCR-Like Antibody Selected Against the Heteroclitic Variant of a Shared MAGE-A Epitope Do Not Recognise the Cognate EpitopeMesha Saeed, Erik Schooten, Mandy van Brakel, et al.
Plos One|May 29, 2014
The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunityAnne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, et al.
Oncoimmunology|May 6, 2015
The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunityAnne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken, et al.
Pageof 14